205 related articles for article (PubMed ID: 36059866)
1. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
[TBL] [Abstract][Full Text] [Related]
2. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
Nguyen HT; Falzarano D; Gerdts V; Liu Q
J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
[TBL] [Abstract][Full Text] [Related]
3. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 replicon for high-throughput antiviral screening.
Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
[TBL] [Abstract][Full Text] [Related]
6. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.
Jin YY; Lin H; Cao L; Wu WC; Ji Y; Du L; Jiang Y; Xie Y; Tong K; Xing F; Zheng F; Shi M; Pan JA; Peng X; Guo D
Virol Sin; 2021 Oct; 36(5):913-923. PubMed ID: 33999369
[TBL] [Abstract][Full Text] [Related]
7. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
Zhang Y; Song W; Chen S; Yuan Z; Yi Z
Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
[TBL] [Abstract][Full Text] [Related]
8. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
[TBL] [Abstract][Full Text] [Related]
9. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.
Wang L; Guzman M; Muñoz-Santos D; Honrubia JM; Ripoll-Gomez J; Delgado R; Sola I; Enjuanes L; Zuñiga S
Front Cell Infect Microbiol; 2023; 13():1268227. PubMed ID: 37942479
[TBL] [Abstract][Full Text] [Related]
10. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
11. Minireview of progress in the structural study of SARS-CoV-2 proteins.
Zhu G; Zhu C; Zhu Y; Sun F
Curr Res Microb Sci; 2020 Sep; 1():53-61. PubMed ID: 33236001
[TBL] [Abstract][Full Text] [Related]
12. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
[TBL] [Abstract][Full Text] [Related]
13. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
Liu S; Chou CK; Wu WW; Luan B; Wang TT
J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
[TBL] [Abstract][Full Text] [Related]
14. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
[TBL] [Abstract][Full Text] [Related]
15. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
[TBL] [Abstract][Full Text] [Related]
16. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
[TBL] [Abstract][Full Text] [Related]
17. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
[TBL] [Abstract][Full Text] [Related]
18. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
Ghorbani A; Samarfard S; Ramezani A; Izadpanah K; Afsharifar A; Eskandari MH; Karbanowicz TP; Peters JR
Infect Genet Evol; 2020 Nov; 85():104556. PubMed ID: 32937193
[TBL] [Abstract][Full Text] [Related]
19. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
20. Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication.
Wang X; Zhu Y; Wu Q; Jiang N; Xie Y; Deng Q
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
